NasdaqGS:BBIOBiotechs
Is BridgeBio Pharma (BBIO) Still Attractively Priced After Strong Pipeline Progress And 7x Gain?
If you are wondering whether BridgeBio Pharma's share price still makes sense after a strong run, this article focuses on what the numbers say about value rather than the excitement around the stock.
The stock trades at US$77.81, with returns of 2.0% over the past week, 2.7% over the past month, a slight year to date decline of 0.5%, a 112.2% return over the past year, a very large 3 year gain that is around 7x, and a 35.5% return over 5 years.
Recent news around BridgeBio has centered on...